Office Action Predictor
Last updated: April 15, 2026

Shanghai Qilu Pharmaceutical Research And Development Centre LTD.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18549186 FURAN FUSED RING-SUBSTITUTED GLUTARIMIDE COMPOUND BREDEFELD, RACHAEL EVA 3786 Final Rejection Sep 06, 2023
18036361 BISPECIFIC ANTIBODY FOR CLAUDIN 18A2 AND CD3 AND APPLICATION OF BISPECIFIC ANTIBODY SHUPE, ELIZABETH A 1643 Non-Final OA May 10, 2023

Managing Shanghai Qilu Pharmaceutical Research And Development Centre LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month